Luyan Pharma financials at a glance

+ Portfolio

The revenue of Luyan Pharma is reported as 21.603 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.98 Yuan Renminbi per share in 2023, which was 6.52 higher than 2018. And about -0.52921 billion Yuan Renminbi are reported as free cash flow in the financials of Luyan Pharma 2023. Dividends of 0.34 Yuan Renminbi per share were paid to shareholders of Luyan Pharma stock SZSE:002788 in fiscal 2023.

¥21.60B

Revenue

¥0.98

Earnings Per Share

7.59%

Gross Margin %

¥0.00M

Free Cash Flow

Revenue

21,603.00

Earnings Per Share

0.98

Gross Margin %

7.59

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2018
Rev.	Revenue	N/A	¥21.60B	¥11.50B
GM %	Gross Margin %	7.61%	7.59%	7.75%
OM	Operating Margin	3.51%	3.50%	3.31%
EPS	Earnings Per Share	¥0.91	¥0.98	¥0.92
Div.	Dividends	N/A	¥0.34	¥0.00
PR %	Payout Ratio %	0	34.69%	0
Sha.	Shares	N/AM	388.52M	326.83M
OCF	Operating Cash Flow	N/A	¥0.00M	¥0.00M
FCF	Free Cash Flow	N/A	¥0.00M	¥0.00M
FCFS	Free Cash Flow Per Share	¥0.82	¥2.02	¥-0.02

Luyan Pharma financials at a glance

Financials

Discover